Vitamin C and cancer
This article was originally published in The Tan Sheet
Executive Summary
Oral vitamin C administration does not produce "high plasma and urine concentrations that might have antitumor activity," Sebastian Padayatty, PhD, NIH, et al., report in the April 6 Annals of Internal Medicine. Researchers measured vitamin C plasma and urine concentrations after giving oral or intravenous doses to 17 patients. Authors maintain that vitamin's role in cancer treatment should be reevaluated, since "efficacy of vitamin C...cannot be judged from clinical trials that use only oral dosing"...
You may also be interested in...
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.